Who Supplies Tenofovir? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Tenofovir exports, with 296+ registered manufacturers shipping to buyers across 182+ countries — yet a handful of companies dominate the shipments. MACLEODS PHARMACEUTICALS LTD holds the largest share at 73.7% (export value: $3.2B). Close behind, MYLAN LABORATORIES LIMITED (1.3%, $57.0M). HETERO LABS LIMITED (1.2%, $50.3M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.

🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Tenofovir? Top Manufacturers & Their Buyers
Flow of Tenofovir from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Tenofovir Supplier Network — Key Market Intelligence
The Tenofovir export market from India is led by MACLEODS PHARMACEUTICALS LTD, which alone commands a 73.7% share, shipping $3.2B worth of product across 519 shipments. The second-largest exporter, MYLAN LABORATORIES LIMITED, contributes $57.0M (1.3%) to the overall market. Combined, the top two suppliers alone account for 75.0% of all Tenofovir exports, indicating a relatively concentrated supply base.
Across all 296 tracked manufacturers, the total Tenofovir export value stands at $4.3B from 7.5K shipments. The market average shipment value is $575.8K. The single largest buyer relationship in terms of trade value is AFRICURE PHARMACEUTICALS BOTSWANA, receiving $3.1B worth of product.
The combined buyer network spans 22 named purchasing companies, including AFRICURE PHARMACEUTICALS BOTSWANA, MACLEODS PHARMACEUTICALS SA, CENAME ON BEHALF OF THE MINISTRY, ZYDUS FRANCE, KENYA MEDICAL SUPPLIES and 17 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the first-largest Tenofovir exporter from India, with a market share of 73.7% and a total export value of $3.2B across 519 shipments. Their average shipment value of $6.1M is above the market average of $575.8K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. AFRICURE PHARMACEUTICALS BOTSWANA is the dominant customer, accounting for 98.6% of this supplier's tracked business. Top customers include:
• AFRICURE PHARMACEUTICALS BOTSWANA — $3.1B across 512 shipments (98.6% of this supplier's total exports)
• AFRICURE PHARMACEUTICALS BOTSWANA — $15.4M across 3 shipments (0.5% of this supplier's total exports)
• MACLEODS PHARMACEUTICALS SA — $10.8M across 2 shipments (0.3% of this supplier's total exports)
• CENAME ON BEHALF OF THE MINISTRY — $10.6M across 2 shipments (0.3% of this supplier's total exports)
• ZYDUS FRANCE — $8.1M across 1 shipments (0.3% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $6.1M is 968% above the market average of $575.8K, consistent with large-order contracts or value-added formulations.
2MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the second-largest Tenofovir exporter from India, with a market share of 1.3% and a total export value of $57.0M across 1.0K shipments. Their average shipment value of $56.8K is below the market average of $575.8K, reflecting a high-volume, competitive pricing strategy.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• KENYA MEDICAL SUPPLIES — $21.0M across 369 shipments (36.9% of this supplier's total exports)
• VIATRIS HEALTHCARE (PTY) LTD, — $14.0M across 246 shipments (24.6% of this supplier's total exports)
• NATIONAL AIDS COUNCIL (NAC), — $9.9M across 174 shipments (17.4% of this supplier's total exports)
• VIATRIS HEALTHCARE P — $6.1M across 107 shipments (10.7% of this supplier's total exports)
• XXLANXXABOXXTORXXS L — $6.0M across 105 shipments (10.5% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (1.0K shipments) at a per-shipment value of $56.8K, indicating a broad distribution network with many smaller, regular orders.
3HETERO LABS LIMITED
HETERO LABS LIMITED is the third-largest Tenofovir exporter from India, with a market share of 1.2% and a total export value of $50.3M across 1.3K shipments. Their average shipment value of $39.1K is below the market average of $575.8K, reflecting a high-volume, competitive pricing strategy.
HETERO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $15.9M across 405 shipments (31.6% of this supplier's total exports)
• TO THE ORDER — $13.1M across 334 shipments (26.0% of this supplier's total exports)
• TO THE ORDER — $9.5M across 243 shipments (18.9% of this supplier's total exports)
• NA — $5.9M across 151 shipments (11.8% of this supplier's total exports)
• CHEM-I-PLAST PTY LIM — $5.9M across 150 shipments (11.7% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED operates with high shipment frequency (1.3K shipments) at a per-shipment value of $39.1K, indicating a broad distribution network with many smaller, regular orders.
4STRIDES PHARMA SCIENCE LIMITED
STRIDES PHARMA SCIENCE LIMITED is the fourth-largest Tenofovir exporter from India, with a market share of 1.1% and a total export value of $47.6M across 75 shipments. Their average shipment value of $635.3K is above the market average of $575.8K, suggesting premium or bulk contract pricing.
STRIDES PHARMA SCIENCE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MINISTERE DE SANTE PUBLIQUE SG/MSP — $18.5M across 29 shipments (38.8% of this supplier's total exports)
• MINISTERIO DA SAUDE — $13.6M across 21 shipments (28.5% of this supplier's total exports)
• MINISTRY OF HEALTH — $8.1M across 13 shipments (17.0% of this supplier's total exports)
• NATIONAL MEDICAL STORES — $4.6M across 7 shipments (9.6% of this supplier's total exports)
• MINISTRY OF HEALTH G — $2.9M across 5 shipments (6.1% of this supplier's total exports)
Key Insight: STRIDES PHARMA SCIENCE LIMITED's per-shipment value of $635.3K is 10% above the market average of $575.8K, consistent with large-order contracts or value-added formulations.
5EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the fifth-largest Tenofovir exporter from India, with a market share of 0.9% and a total export value of $40.2M across 279 shipments. Their average shipment value of $144.0K is below the market average of $575.8K, reflecting a high-volume, competitive pricing strategy.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• EMCURE PHARMACEUTICALS SA (PTY) LTD — $13.8M across 96 shipments (34.4% of this supplier's total exports)
• MINISTRY OF HEALTH AND CHILD CARE — $9.1M across 63 shipments (22.6% of this supplier's total exports)
• UNITED NATIONS DEVELOPMENT PROGRAMM — $7.2M across 50 shipments (17.8% of this supplier's total exports)
• UNITED NATIONS OFFIC — $5.2M across 36 shipments (13.0% of this supplier's total exports)
• SYNERMEDICA KENYA LI — $4.8M across 34 shipments (12.1% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED operates with high shipment frequency (279 shipments) at a per-shipment value of $144.0K, indicating a broad distribution network with many smaller, regular orders.
6CIPLA LIMITED
CIPLA LIMITED is the fifth-largest Tenofovir exporter from India, with a market share of 0.4% and a total export value of $17.8M across 808 shipments. Their average shipment value of $22.0K is below the market average of $575.8K, reflecting a high-volume, competitive pricing strategy.
CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MINISTRY OF HEALTH AND CHILD CARE — $4.2M across 192 shipments (23.8% of this supplier's total exports)
• MINISTRY OF HEALTH AND CHILD CARE — $3.8M across 174 shipments (21.6% of this supplier's total exports)
• NA — $3.5M across 158 shipments (19.5% of this supplier's total exports)
• PROGRAMME NATIONAL D — $3.4M across 154 shipments (19.0% of this supplier's total exports)
• IN THE NAME OF COMME — $2.9M across 130 shipments (16.1% of this supplier's total exports)
Key Insight: CIPLA LIMITED operates with high shipment frequency (808 shipments) at a per-shipment value of $22.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Tenofovir Flows
Once Tenofovir leaves the manufacturing plants of companies like MACLEODS PHARMACEUTICALS LTD and MYLAN LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $4.3B. Botswana absorbs the largest share at 73.3% ($3.2B), followed by Tanzania (6.1%) and Kenya (4.1%).
In Botswana — the top destination — named importers include AFRICURE PHARMACEUTICALS BOTSWANA(P, AFRICURE PHARMACEUTICALS BOTSWANA.
This geographic spread reflects Tenofovir's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Tenofovir Go? Top Importing Countries & Their Buyers
Trade flow of Tenofovir exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Botswana
Botswana ranks as the first-largest destination for Tenofovir imports from India, with a total trade value of $3.2B across 25 shipments — representing a 73.3% share of all Tenofovir exports. The average shipment value of $126.9M is above the global average of $575.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Tenofovir importers in Botswana: AFRICURE PHARMACEUTICALS BOTSWANA(P is the largest buyer, accounting for 99.1% ($3.1B) of this market's total imports.
• AFRICURE PHARMACEUTICALS BOTSWANA(P — $3.1B (99.1% of Botswana's total)
• AFRICURE PHARMACEUTICALS BOTSWANA — $17.5M (0.6% of Botswana's total)
Key Insight: Botswana's per-shipment average of $126.9M (21944% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Botswana is a key market for Tenofovir imports from India.
2Tanzania
Tanzania ranks as the second-largest destination for Tenofovir imports from India, with a total trade value of $264.4M across 0 shipments — representing a 6.1% share of all Tenofovir exports. The average shipment value of $264.4M is above the global average of $575.8K, indicating high-value procurement contracts or branded formulations.
Key Insight: Tanzania's per-shipment average of $264.4M (45815% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tanzania is a key market for Tenofovir imports from India.
3Kenya
Kenya ranks as the third-largest destination for Tenofovir imports from India, with a total trade value of $175.5M across 12 shipments — representing a 4.1% share of all Tenofovir exports. The average shipment value of $14.6M is above the global average of $575.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Tenofovir importers in Kenya: KENYA MEDICAL SUPPLIES is the largest buyer, accounting for 12.0% ($21.0M) of this market's total imports.
• KENYA MEDICAL SUPPLIES — $21.0M (12.0% of Kenya's total)
Key Insight: Kenya's per-shipment average of $14.6M (2439% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kenya is a key market for Tenofovir imports from India.
4South Africa
South Africa ranks as the fourth-largest destination for Tenofovir imports from India, with a total trade value of $115.2M across 86 shipments — representing a 2.7% share of all Tenofovir exports. The average shipment value of $1.3M is above the global average of $575.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Tenofovir importers in South Africa: VIATRIS HEALTHCARE (PTY) LTD, is the largest buyer, accounting for 12.5% ($14.4M) of this market's total imports.
• VIATRIS HEALTHCARE (PTY) LTD, — $14.4M (12.5% of South Africa's total)
• EMCURE PHARMACEUTICALS SA (PTY) LTD — $13.9M (12.0% of South Africa's total)
• MACLEODS PHARMACEUTICALS SA — $11.7M (10.2% of South Africa's total)
Key Insight: South Africa's per-shipment average of $1.3M (133% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Tenofovir imports from India.
5Mozambique
Mozambique ranks as the fifth-largest destination for Tenofovir imports from India, with a total trade value of $81.7M across 10 shipments — representing a 1.9% share of all Tenofovir exports. The average shipment value of $8.2M is above the global average of $575.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Tenofovir importers in Mozambique: MINISTERIO DA SAUDE is the largest buyer, accounting for 21.7% ($17.7M) of this market's total imports.
• MINISTERIO DA SAUDE — $17.7M (21.7% of Mozambique's total)
• I SOLUTIONS POLANERBAAN 11 — $7.3M (8.9% of Mozambique's total)
Key Insight: Mozambique's per-shipment average of $8.2M (1319% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mozambique is a key market for Tenofovir imports from India.
People Also Ask — Tenofovir Supplier & Trade Network
Who are the top suppliers of Tenofovir from India?+
Which companies buy Tenofovir from Indian manufacturers?+
Where does Tenofovir exported from India go?+
What is the market share of the top Tenofovir supplier from India?+
What is the average shipment value for Tenofovir exports from India?+
Is Tenofovir manufactured in India and exported globally?+
Which country imports the most Tenofovir from India?+
Who are the buyers of Tenofovir in Tanzania?+
How concentrated is the Tenofovir supplier market in India?+
How do I find verified buyers for Tenofovir in specific countries?+
Tenofovir Trade Network — Key Takeaways
- 1MACLEODS PHARMACEUTICALS LTD is India's dominant Tenofovir exporter with a 73.7% market share and $3.2B in total exports — making it the single most important sourcing entity in this market.
- 2The top 296 suppliers collectively account for 78.6% of all tracked Tenofovir exports, with a combined trade value of $4.3B.
- 3Botswana is the largest destination market, absorbing 73.3% of India's Tenofovir exports ($3.2B). Tanzania (6.1%) and Kenya (4.1%) follow.
- 4With 7.5K total shipments averaging $575.8K each, the Tenofovir export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AFRICURE PHARMACEUTICALS BOTSWANA, AFRICURE PHARMACEUTICALS BOTSWANA, KENYA MEDICAL SUPPLIES, VIATRIS HEALTHCARE (PTY) LTD, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 182 countries
Network value: $4.3B
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tenofovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Tenofovir.
- 2.Flow Mapping: 296 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 7,518 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 182 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7,518 Verified Shipments
296 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists